Jefferies Group's RANI Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 22,221 shares of Rani Therapeutics Holdings, Inc. (RANI) worth $16,328, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in RANI, representing a fresh investment thesis on this company. Largest reduction occurred in Q1 2026, reducing 7,649 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Rani Therapeutics Holdings (RANI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rani Therapeutics Holdings (RANI) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -7,649 | Reduce 25.61% | 22,221 | $0.73 |
| Q4 2025 | +29,870 | New Buy | 29,870 | $1.35 |
Jefferies Group's Rani Therapeutics Holdings Investment FAQs
Jefferies Group first purchased Rani Therapeutics Holdings, Inc. (RANI) in Q4 2025, acquiring 29,870 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Rani Therapeutics Holdings, Inc. (RANI) for 2 quarters since Q4 2025.
Jefferies Group's largest addition to Rani Therapeutics Holdings, Inc. (RANI) was in Q4 2025, adding 29,870 shares worth $40,325.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 22,221 shares of Rani Therapeutics Holdings, Inc. (RANI), valued at approximately $16,328.
As of the Q1 2026 filing, Rani Therapeutics Holdings, Inc. (RANI) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Rani Therapeutics Holdings, Inc. (RANI) was 29,870 shares, as reported at the end of Q4 2025.